Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Prosperity Wealth Management Inc.

Prosperity Wealth Management Inc. lessened its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 50.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 817 shares of the biotechnology company’s stock after selling 824 shares during the period. Prosperity Wealth Management Inc.’s holdings in Axon Enterprise were worth $486,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Prestige Wealth Management Group LLC raised its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the period. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $40,000. Brooklyn Investment Group bought a new position in Axon Enterprise in the 3rd quarter worth approximately $41,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise in the 4th quarter worth approximately $45,000. Finally, Planning Capital Management Corp lifted its position in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on AXON. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday. Finally, JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Insiders Place Their Bets

In related news, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the sale, the insider now owns 124,243 shares of the company’s stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,146 shares of company stock valued at $3,262,847. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Up 2.2 %

Axon Enterprise stock opened at $526.64 on Wednesday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The stock has a market cap of $40.35 billion, a PE ratio of 136.08, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The firm’s 50-day simple moving average is $596.28 and its 200 day simple moving average is $532.72. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.